Negative regulation of activation-induced cytidine deaminase in B cells
Author(s) -
Taro Muto,
Ilmi Okazaki,
Shuichi Yamada,
Yoshimasa Tanaka,
Kazuo Kinoshita,
Masamichi Muramatsu,
Hitoshi Nagaoka,
Tasuku Honjo
Publication year - 2006
Publication title -
proceedings of the national academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.0510970103
Subject(s) - somatic hypermutation , cytidine deaminase , activation induced (cytidine) deaminase , germinal center , immunoglobulin class switching , transgene , biology , b cell , genetically modified mouse , microbiology and biotechnology , gene , antibody , genetics
Both class switch recombination (CSR) and somatic hypermutation (SHM) of the Ig genes require the activity of activation-induced cytidine deaminase (AID). Expression of AID is restricted to B cells in the germinal centers of the lymphoid organs, where activated B cells undergo CSR and SHM. We previously showed that constitutive and systemic expression of AID leads to tumorigenesis in T cells and lung epithelium, but not in B cells. This finding led us to suspect that transgenic AID may be inactivated at least in part in B cells. To address this issue, we generated conditional AID-transgenic mice that constitutively express AID only in B cells. Studies on the cross between the AID-transgenic and AID-deficient mice showed that abundant AID protein accumulated by constitutive expression is inactivated in B cells, possibly providing an explanation for the absence of deregulation of CSR and SHM in AID-transgenic B cells.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom